In the News Archive
- 2014-06-23 - Results from Phase III Study (AML-001) of VIDAZA® (Azacitidine for Injection) in Acute Myeloid Leukemia Presented at EHA
- 2014-06-23 - BioLineRx Receives Approval to Commence Phase 1 Trial for Novel Stem Cell Mobilization Treatment
- 2014-06-23 - MacroGenics Begins Phase 1 Trial Of MGD006 For Acute Myeloid Leukemia Treatment
- 2014-06-05 - Children who remain leukemia-free 5 years after diagnosis considered cured
- 2014-06-05 - Major discovery on the mechanism of drug resistance in leukemia and other cancers
- 2014-06-05 - Scientists Discover How Leukemia and Other Cancers Become Resistant to Drugs
- 2014-06-05 - AbbVie Presents New Results from Studies of Investigational Oncology Compound ABT-199/GDC-0199 at the 2014 American Society of Clinical Oncology Annual Meeting
- 2014-06-05 - ARIAD Announces Preliminary Safety and Efficacy Data of Ponatinib in Patients with Newly Diagnosed CML from Discontinued Phase 3 EPIC Trial
- 2014-06-05 - Lenalidomide, rituximab achieved responses in treatment-naive patients with follicular lymphoma
- 2014-05-27 - Karyopharm Receives Orphan Drug Designation for Acute Myeloid Leukemia (AML)
- 2014-05-27 - PET/CT predicted outcomes in primary mediastinal large B-cell lymphoma
- 2014-05-27 - The Stem Cell Revolution Targeting Leukemia
- 2014-05-27 - What to Watch in Lymphoma, Leukemia
- 2014-05-15 - Drug to fight leukemia in sight, say Australian researchers
- 2014-05-15 - Frontline Treatment of Hodgkin Lymphoma